Celator raises $20 million

Celator Pharmaceuticals Inc. (Princeton, N.J.) raised $20 million in a series D round led by new investor Thomas, McNerney. Existing investors Domain Associates; Ventures West; Quaker BioVentures; TL Ventures; GrowthWorks Capital; and BDC Venture Capital also participated. ...